Maximum Strength Mucinex Fast-max Night Time Cold And Flu
Pricing Report NDC 63824-500-66
View Wholesale Price per Unit, Acquisition Costs, and Historic Pricing Trends
Current Package Pricing Information
This product is EXCLUDED from the official NDC directory because the listing data was discontinued by the firm.
The latest wholesale acquisition cost for Maximum Strength Mucinex Fast-max Night Time Cold And Flu (NDC 63824-500-66) is $0.05826 per ML. This benchmark price is based on the National Average Drug Acquisition Cost (NADAC) and has been effective since Nov 20, 2019.
As a provided by Rb Health (us) Llc, this medication is distributed in a 180 mL in 1 BOTTLE configuration. The pricing data is derived from C/I - Chain or Independent Pharmacy surveys, reflecting the actual invoice prices paid by community pharmacies to drug wholesalers.
NADAC Pricing Summary
NADAC pricing snapshot for this package NDC
Acquisition Cost $0.05826 Per ML
Pricing Unit
Effective Date
Nov 20, 2019
Billable Units
180 ML
Estimated Package Price
$10.49
Data Status
As of Nov 11, 2020
Pricing Methodology Explanation
The NADAC was carried forward from the previous file.
The NADAC was calculated based on package size.
The CMS Covered Outpatient File drug category type of S/I/N (Single Source/Innovator/Non-Innovator) has not been applied. Most S/I drugs with the same strength, dosage form and route of administration were grouped together for the purpose of the NADAC calculation and N drugs were also grouped together. In some cases, however, in calculating a NADAC, the CMS S/I/N designation was not applied when the state Medicaid brand or generic payment practices for these drugs generally differed from the CMS Covered Outpatient File designation.
The NADAC was calculated based on package size.
The CMS Covered Outpatient File drug category type of S/I/N (Single Source/Innovator/Non-Innovator) has not been applied. Most S/I drugs with the same strength, dosage form and route of administration were grouped together for the purpose of the NADAC calculation and N drugs were also grouped together. In some cases, however, in calculating a NADAC, the CMS S/I/N designation was not applied when the state Medicaid brand or generic payment practices for these drugs generally differed from the CMS Covered Outpatient File designation.
Historical Pricing Trends & Acquisition Cost Benchmarks
Since May 2014, the NADAC wholesale price for (NDC ) has moved within a range of $0.04621 to $0.06184 per ML. Over this 7 years and 11 months period, the pricing trend reflects the shifting acquisition costs reported by retail and chain pharmacies to the Centers for Medicare and Medicaid Services (CMS). The following interactive chart and historical table detail every recorded price adjustment based on these federal surveys.
Price Range
$0.0462 - $0.0618
$0.0462 - $0.0618
Market Volatility
33.82% Variance
33.82% Variance
Latest Trend
6.14%
6.14%
| Date | Unit Price | Unit | Source | Method | Rate |
|---|---|---|---|---|---|
| Apr 20, 2022 | $0.06184 | ML | C/I - Chain or Independent Pharmacy | Code 1, 5, 6 | B - Brand |
| Apr 20, 2022 | $0.06184 | ML | C/I - Chain or Independent Pharmacy | Code 4, 5, 6 | B - Brand |
| Nov 20, 2019 | $0.05826 | ML | C/I - Chain or Independent Pharmacy | Code 1, 5, 6 | B - Brand |
| Nov 20, 2019 | $0.05826 | ML | C/I - Chain or Independent Pharmacy | Code 2, 5, 6 | B - Brand |
| Nov 20, 2019 | $0.05826 | ML | C/I - Chain or Independent Pharmacy | Code 4, 5, 6 | B - Brand |
| Jul 17, 2019 | $0.05508 | ML | C/I - Chain or Independent Pharmacy | Code 1, 5, 6 | B - Brand |
| Jul 17, 2019 | $0.05508 | ML | C/I - Chain or Independent Pharmacy | Code 4, 5, 6 | B - Brand |
| Jun 19, 2019 | $0.05383 | ML | C/I - Chain or Independent Pharmacy | Code 1, 5, 6 | B - Brand |
| Mar 01, 2019 | $0.05725 | ML | C/I - Chain or Independent Pharmacy | Code 3, 5, 6 | B - Brand |
| Mar 01, 2019 | $0.05725 | ML | C/I - Chain or Independent Pharmacy | Code 4, 5, 6 | B - Brand |
| Jun 20, 2018 | $0.05163 | ML | C/I - Chain or Independent Pharmacy | Code 1, 5, 6 | B - Brand |
| Jun 20, 2018 | $0.05163 | ML | C/I - Chain or Independent Pharmacy | Code 2, 5, 6 | B - Brand |
| Jun 20, 2018 | $0.05163 | ML | C/I - Chain or Independent Pharmacy | Code 4, 5, 6 | B - Brand |
| May 23, 2018 | $0.05360 | ML | C/I - Chain or Independent Pharmacy | Code 1, 5, 6 | B - Brand |
| Apr 18, 2018 | $0.05511 | ML | C/I - Chain or Independent Pharmacy | Code 1, 5, 6 | B - Brand |
| Mar 21, 2018 | $0.05394 | ML | C/I - Chain or Independent Pharmacy | Code 1, 5, 6 | B - Brand |
| Feb 21, 2018 | $0.05179 | ML | C/I - Chain or Independent Pharmacy | Code 1, 5, 6 | B - Brand |
| Jan 17, 2018 | $0.05566 | ML | C/I - Chain or Independent Pharmacy | Code 1, 5, 6 | B - Brand |
| Nov 22, 2017 | $0.05396 | ML | C/I - Chain or Independent Pharmacy | Code 1, 5, 6 | B - Brand |
| Nov 22, 2017 | $0.05396 | ML | C/I - Chain or Independent Pharmacy | Code 2, 5, 6 | B - Brand |
| Sep 20, 2017 | $0.05225 | ML | C/I - Chain or Independent Pharmacy | Code 1, 5, 6 | B - Brand |
| Sep 20, 2017 | $0.05225 | ML | C/I - Chain or Independent Pharmacy | Code 4, 5, 6 | B - Brand |
| Aug 23, 2017 | $0.05585 | ML | C/I - Chain or Independent Pharmacy | Code 1, 5, 6 | B - Brand |
| Jul 19, 2017 | $0.05251 | ML | C/I - Chain or Independent Pharmacy | Code 1, 5, 6 | B - Brand |
| May 17, 2017 | $0.05320 | ML | C/I - Chain or Independent Pharmacy | Code 1, 5, 6 | B - Brand |
| May 17, 2017 | $0.05320 | ML | C/I - Chain or Independent Pharmacy | Code 4, 5, 6 | B - Brand |
| Mar 22, 2017 | $0.04734 | ML | C/I - Chain or Independent Pharmacy | Code 1, 5, 6 | B - Brand |
| Mar 22, 2017 | $0.04734 | ML | C/I - Chain or Independent Pharmacy | Code 4, 5, 6 | B - Brand |
| Dec 21, 2016 | $0.05300 | ML | C/I - Chain or Independent Pharmacy | Code 1, 5, 6 | B - Brand |
| Dec 21, 2016 | $0.05300 | ML | C/I - Chain or Independent Pharmacy | Code 2, 5, 6 | B - Brand |
| Nov 23, 2016 | $0.05429 | ML | C/I - Chain or Independent Pharmacy | Code 1, 5, 6 | B - Brand |
| Jul 20, 2016 | $0.05543 | ML | C/I - Chain or Independent Pharmacy | Code 1, 5, 6 | B - Brand |
| Jul 20, 2016 | $0.05543 | ML | C/I - Chain or Independent Pharmacy | Code 4, 5, 6 | B - Brand |
| May 18, 2016 | $0.05122 | ML | C/I - Chain or Independent Pharmacy | Code 2, 5, 6 | B - Brand |
| May 18, 2016 | $0.05122 | ML | C/I - Chain or Independent Pharmacy | Code 3, 5, 6 | B - Brand |
| Apr 20, 2016 | $0.05355 | ML | C/I - Chain or Independent Pharmacy | Code 3, 5, 6 | B - Brand |
| Mar 23, 2016 | $0.04992 | ML | C/I - Chain or Independent Pharmacy | Code 1, 5, 6 | B - Brand |
| Feb 17, 2016 | $0.04906 | ML | C/I - Chain or Independent Pharmacy | Code 1, 5, 6 | B - Brand |
| Jan 20, 2016 | $0.04738 | ML | C/I - Chain or Independent Pharmacy | Code 1, 5, 6 | B - Brand |
| Dec 23, 2015 | $0.05210 | ML | C/I - Chain or Independent Pharmacy | Code 1, 5, 6 | B - Brand |
| Aug 19, 2015 | $0.04944 | ML | C/I - Chain or Independent Pharmacy | Code 3, 5, 6 | B - Brand |
| Aug 19, 2015 | $0.04944 | ML | C/I - Chain or Independent Pharmacy | Code 4, 5, 6 | B - Brand |
| Jul 22, 2015 | $0.04880 | ML | C/I - Chain or Independent Pharmacy | Code 3, 5, 6 | B - Brand |
| Mar 18, 2015 | $0.04960 | ML | C/I - Chain or Independent Pharmacy | Code 1, 5, 6 | B - Brand |
| Mar 18, 2015 | $0.04960 | ML | C/I - Chain or Independent Pharmacy | Code 2, 5, 6 | B - Brand |
| Feb 18, 2015 | $0.04744 | ML | C/I - Chain or Independent Pharmacy | Code 1, 5, 6 | B - Brand |
| May 14, 2014 | $0.04621 | ML | C/I - Chain or Independent Pharmacy | Code 1, 5 | B - Brand |
| May 14, 2014 | $0.04621 | ML | C/I - Chain or Independent Pharmacy | Code 2, 5 | B - Brand |
| May 14, 2014 | $0.04621 | ML | C/I - Chain or Independent Pharmacy | Code 2, 5, 6 | B - Brand |
| May 14, 2014 | $0.04621 | ML | C/I - Chain or Independent Pharmacy | Code 4, 5 | B - Brand |
| May 14, 2014 | $0.04621 | ML | C/I - Chain or Independent Pharmacy | Code 4, 5, 6 | B - Brand |
Pricing Methodology Legend
- Code 1: The NADAC was calculated using information from the most recently completed pharmacy survey.
- Code 2: The average acquisition cost of the most recent survey was within ± 2% of the current NADAC; therefore, the NADAC was carried forward from the previous file.
- Code 3: The NADAC based on survey data has been adjusted to reflect changes in published pricing, or as a result of an inquiry to the help desk.
- Code 4: The NADAC was carried forward from the previous file.
- Code 5: The NADAC was calculated based on package size.
- Code 6: The CMS Covered Outpatient File drug category type of S/I/N (Single Source/Innovator/Non-Innovator) has not been applied. Most S/I drugs with the same strength, dosage form and route of administration were grouped together for the purpose of the NADAC calculation and N drugs were also grouped together. In some cases, however, in calculating a NADAC, the CMS S/I/N designation was not applied when the state Medicaid brand or generic payment practices for these drugs generally differed from the CMS Covered Outpatient File designation.
Understanding NADAC Pricing Data
The National Average Drug Acquisition Cost (NADAC) is compiled by the Centers for Medicare and Medicaid Services (CMS). This data is derived from random monthly surveys of more than 60,000 pharmacies across all 50 states.
Important Price Distinction:
The prices listed on this page represent the wholesale invoice price paid by pharmacies to acquire the drug. This is NOT the retail price paid by consumers at the pharmacy counter. Final patient costs typically include pharmacy markups, professional dispensing fees, and insurance adjustments.
NADAC Pricing Data Last Updated on: July 08, 2026
